Succinic Acid

The dosage of Succinic Acid is highly individualized and depends entirely on the method of administration and the condition being treated.

Urinary Irrigation (Calculi Dissolution)

For the dissolution of kidney or bladder stones, Succinic Acid is typically administered as a sterile irrigation solution.

• Standard Concentration: Solutions like Suby's Solution G contain approximately 3.8g of citric acid and varying amounts of Succinic Acid or its salts per 1000 mL.
• Rate of Administration: The solution is usually instilled at a rate of 30 to 60 mL per hour through a nephrostomy tube or catheter.
• Duration: Irrigation may continue for several days or weeks until follow-up imaging (X-ray or ultrasound) confirms the dissolution of the stone.

Oral Supplementation (Off-label/Nutraceutical)

When used for metabolic support, doses typically range from 100 mg to 500 mg daily. However, clinical data supporting specific oral doses for systemic conditions are limited compared to its use in urology.

Succinic Acid is not routinely approved for pediatric use in the context of stone dissolution unless specifically directed by a pediatric urologist.

• Safety: The safety and efficacy in children have not been established through large-scale clinical trials.
• Dosing: If used, dosing is typically calculated based on body surface area or the volume capacity of the child's bladder. Healthcare providers must exercise extreme caution to avoid systemic electrolyte imbalances in smaller patients.

Renal Impairment

Patients with significant renal impairment (decreased kidney function) must be monitored closely. While the drug is used locally, any systemic absorption can lead to metabolic challenges. No specific dose adjustment is standardized, but the rate of irrigation may be slowed if the patient cannot adequately clear the absorbed components.

Hepatic Impairment

No dosage adjustments are typically required for patients with liver disease, as Succinic Acid metabolism is primarily mitochondrial and occurs throughout the body's tissues rather than being localized to the liver.

Elderly Patients

Geriatric patients may have thinner mucosal linings in the urinary tract, increasing the risk of systemic absorption and local irritation. Providers often start at the lower end of the irrigation rate spectrum (e.g., 20-30 mL/hour).

For Irrigation

1. 1Sterility: Succinic Acid irrigation solutions must remain sterile. Do not use the solution if it is cloudy or contains particles.
2. 2Temperature: The solution should be at room temperature or slightly warmed to body temperature (37°C) to prevent bladder spasms.
3. 3Positioning: Your healthcare provider will instruct you on the proper positioning to ensure the solution stays in contact with the stone for the required duration.
4. 4Storage: Store solutions in a cool, dry place away from direct sunlight. Do not freeze.

For Oral Forms

• If taking a succinate salt or supplement, it is generally recommended to take it with food to minimize potential gastrointestinal upset.
• Swallow tablets whole; do not crush or chew unless specifically instructed by the manufacturer.

In a clinical setting (irrigation), a 'missed dose' usually refers to an interruption in the continuous flow of the solution. If the irrigation stops, contact your healthcare provider immediately. For oral supplements, if you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double the dose to catch up.

An overdose of Succinic Acid is rare when used as an irrigant but can occur if systemic absorption is excessive or if oral intake is massive.

• Signs of Overdose: Metabolic acidosis (rapid breathing, confusion, fatigue), hypercalcemia (if stones are dissolving too rapidly), or severe gastrointestinal distress.
• Emergency Measures: If an overdose is suspected, irrigation should be stopped immediately. Treatment is supportive, focusing on correcting electrolyte imbalances and maintaining hydration.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the irrigation without medical guidance, as this may lead to stone recurrence or catheter blockage.

When used as a urinary irrigant, Succinic Acid is generally well-tolerated, but local reactions are common due to the acidic nature of the solution.

• Local Irritation: A burning or stinging sensation in the bladder or urethra is reported by many patients. This typically occurs shortly after the start of irrigation.
• Bladder Spasms: The presence of the solution and the catheter can cause the bladder muscles to contract involuntarily, leading to a frequent urge to urinate or pelvic discomfort.
• Increased Urinary Frequency: Patients may feel the need to void more often if the irrigation is being drained naturally through the urethra.

• Hematuria (Blood in Urine): Small amounts of blood may appear in the urine as the stone dissolves or if the catheter causes minor trauma to the bladder lining.
• Nausea: Some patients report mild nausea, which may be a systemic reaction to the absorption of the acid or a secondary effect of pelvic discomfort.
• Low-grade Fever: A slight increase in body temperature may occur as the body reacts to the dissolution process.

• Severe Metabolic Acidosis: If large amounts of Succinic Acid are absorbed systemically, it can lower the blood pH, leading to a medical emergency characterized by deep, rapid breathing (Kussmaul breathing).
• Ureteral Edema: Swelling of the ureter can occur, potentially causing a temporary blockage of urine flow from the kidney to the bladder.
• Allergic Reactions: Though Succinic Acid is endogenous, the additives or the specific preparation may cause hypersensitivity in rare cases.

> Warning: Stop using Succinic Acid and call your doctor immediately if you experience any of the following serious symptoms:

• Severe Abdominal or Flank Pain: This may indicate a blockage or a perforation of the urinary tract.
• Signs of Anaphylaxis: Including hives, difficulty breathing, swelling of the face, lips, or throat.
• Confusion or Altered Mental Status: This could be a sign of a significant electrolyte imbalance or metabolic acidosis.
• Inability to Urinate: If the irrigation fluid goes in but does not come out, it indicates a serious catheter or ureteral blockage.
• High Fever and Chills: These symptoms may suggest a secondary urinary tract infection (UTI) or urosepsis triggered by the release of bacteria trapped within the stones.

Prolonged use of Succinic Acid irrigation (over several months) may lead to:

• Mucosal Thinning: The chronic exposure to an acidic environment can weaken the lining of the bladder or renal pelvis.
• Electrolyte Derangements: Chronic absorption of succinate and the minerals it chelates (like calcium and magnesium) can lead to long-term imbalances in blood mineral levels.
• Secondary Infections: Long-term catheterization required for irrigation significantly increases the risk of chronic UTIs.

No FDA black box warnings are currently issued for Succinic Acid when used as a calculi dissolution agent or as an excipient. However, clinicians are cautioned regarding its use in patients with compromised urinary tract integrity.

Report any unusual symptoms, especially changes in urine color or persistent pain, to your healthcare provider. Monitoring for side effects is a critical part of the stone dissolution process.

Succinic Acid is a potent chemical agent and must be used under strict medical supervision. It is not a general-purpose supplement for kidney stones and is only effective against specific stone types (struvite and apatite). Using it for other types of stones, such as calcium oxalate or uric acid stones, may be ineffective or even counterproductive.

As of 2026, there are no FDA black box warnings for Succinic Acid. It is considered safe for its intended urological and pharmaceutical uses when administered according to established protocols.

• Urinary Tract Integrity: Succinic Acid should never be used if there is a suspected perforation or 'leak' in the urinary tract. If the acid escapes the bladder or kidney into the abdominal cavity, it can cause severe chemical peritonitis (inflammation of the abdominal lining).
• Active Infection: If a patient has an active, untreated urinary tract infection, the dissolution of stones can release trapped bacteria into the system, potentially leading to sepsis. Infections must be treated with antibiotics before or during Succinic Acid therapy.
• Hypermagnesemia Risk: Many Succinic Acid solutions (like Suby's) contain magnesium. Patients with renal failure may not be able to clear absorbed magnesium, leading to toxicity (weakness, low blood pressure, respiratory depression).
• Allergic Sensitization: As a Standardized Chemical Allergen [EPC], Succinic Acid can cause contact dermatitis in sensitive individuals. Healthcare workers handling the solution should use appropriate protective gear.

Patients undergoing Succinic Acid irrigation require regular monitoring to ensure safety and efficacy:

• Imaging: Periodic X-rays or ultrasounds to track the size of the stone.
• Serum Electrolytes: Regular blood tests to monitor levels of calcium, magnesium, phosphate, and bicarbonate.
• Urine pH: Monitoring the pH of the outflow to ensure the environment remains acidic enough for dissolution but not so acidic as to cause tissue damage.
• Renal Function Tests: Monitoring Creatinine and BUN (Blood Urea Nitrogen) to ensure the kidneys are functioning well during the treatment.

Succinic Acid itself does not typically cause drowsiness or impairment. However, the discomfort associated with urinary catheters and the potential for bladder spasms may affect a patient's ability to concentrate. Patients should assess their comfort levels before driving.

There is no direct chemical interaction between Succinic Acid and alcohol. However, alcohol can irritate the bladder and act as a diuretic, which may worsen the side effects of Succinic Acid irrigation or complicate the management of kidney stones. It is generally advised to avoid alcohol during active treatment.

Succinic Acid irrigation can usually be stopped abruptly once the stone has dissolved or if a complication arises. There is no 'withdrawal' syndrome associated with the acid. However, if it is being used as a salt for another medication (like a beta-blocker), that medication must be tapered according to its specific guidelines.

> Important: Discuss all your medical conditions, especially any history of bladder surgery or kidney disease, with your healthcare provider before starting Succinic Acid therapy.

• Methenamine: Succinic Acid should not be used concurrently with Methenamine (a urinary antiseptic). Methenamine requires an acidic environment to work, but the specific chemical interaction between succinate and methenamine in the urinary tract can lead to the formation of insoluble precipitates, potentially worsening stone formation or catheter blockage.

• Potassium-Sparing Diuretics (e.g., Spironolactone): If Succinic Acid is absorbed systemically, it may influence electrolyte balance. Combining it with drugs that increase potassium levels can lead to hyperkalemia, especially in patients with marginal renal function.
• Calcium Channel Blockers: Since Succinic Acid acts as a calcium chelator, there is a theoretical risk that systemic absorption could interfere with the pharmacodynamics of calcium channel blockers, although this is rarely clinically significant with local irrigation.

• Antacids and Urinary Alkalinizers: Drugs like sodium bicarbonate or potassium citrate work to raise urinary pH. These directly oppose the acidifying action of Succinic Acid, rendering the dissolution therapy ineffective.
• Salicylates (Aspirin): Acidifying the urine with Succinic Acid can decrease the renal excretion of salicylates, potentially leading to higher systemic levels of aspirin and an increased risk of toxicity.

• High-Calcium Foods: While the interaction is indirect, a diet excessively high in calcium may slow the dissolution of calcium-based stones during treatment.
• Caffeine: Caffeine is a bladder irritant and can exacerbate the spasms and frequency associated with Succinic Acid irrigation.

• Vitamin C (Ascorbic Acid): While both are acidifiers, excessive Vitamin C can increase oxalate levels in the urine, which may promote the formation of calcium oxalate stones—a type that Succinic Acid cannot dissolve.
• Magnesium Supplements: Since many irrigation solutions already contain magnesium, taking additional oral magnesium can increase the risk of hypermagnesemia.

• Urinary pH: Succinic Acid will intentionally lower urinary pH, which must be accounted for when interpreting urinalysis results.
• Phosphate Levels: Dissolution of struvite stones can lead to transiently elevated urinary phosphate levels.
• Creatinine Clearance: In rare cases, the presence of succinate in the urine may interfere with certain colorimetric assays for creatinine, potentially giving a false reading of kidney function.

For each major interaction, the primary mechanism is usually pharmacodynamic (opposing or additive effects on pH and electrolytes) or physicochemical (chelation). Management typically involves adjusting the timing of doses or choosing alternative medications that do not affect urinary acidity.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those for heart health, blood pressure, or urinary tract health.

Succinic Acid must NEVER be used in the following circumstances:

1. 1Vesicoureteral Reflux: If a patient has a condition where urine flows backward from the bladder into the kidneys, Succinic Acid irrigation can cause dangerous pressure buildup and chemical irritation in the renal pelvis.
2. 2Urinary Tract Perforation: Any break in the integrity of the bladder or ureter is an absolute contraindication. The solution could leak into the retroperitoneal space or peritoneum, causing severe tissue damage and inflammation.
3. 3Severe Renal Failure: Patients with anuria (inability to produce urine) or end-stage renal disease cannot safely process the minerals (calcium, magnesium) released during stone dissolution, nor can they manage the potential systemic acid load.
4. 4Hypersensitivity: Known allergy to Succinic Acid or any component of the irrigation solution (e.g., citric acid, magnesium carbonate).

Conditions requiring careful risk-benefit analysis include:

• Active Urothelial Malignancy: The presence of bladder or kidney cancer may make the tissue more susceptible to irritation or bleeding from the acidic solution.
• Recent Urinary Tract Surgery: Irrigation should be delayed until surgical sites have sufficiently healed to prevent leakage.
• Chronic Cystitis: Patients with long-standing bladder inflammation may experience intolerable pain during irrigation.

Patients who are sensitive to other dicarboxylic acids (like malic acid or tartaric acid) or other organic acidifying agents (like citric acid) should be monitored closely for cross-reactive allergic symptoms, although such reactions are clinically rare.

> Important: Your healthcare provider will evaluate your complete medical history, including recent surgeries and imaging studies, before prescribing Succinic Acid to ensure your urinary tract is intact and capable of handling the treatment.

Succinic Acid is classified as FDA Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women.

• Risk Summary: Because Succinic Acid is an endogenous metabolite, it is not expected to be teratogenic at physiological levels. However, the use of concentrated irrigation solutions during pregnancy carries risks of electrolyte imbalance and pelvic irritation that could potentially trigger uterine contractions.
• Clinical Recommendation: Succinic Acid should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Most urologists prefer to delay stone dissolution until postpartum unless the stone is causing severe obstruction or infection.

It is not known whether Succinic Acid administered via irrigation is excreted in human milk in significant quantities.

• Considerations: Since it is a natural component of human metabolism, small amounts are unlikely to harm a nursing infant. However, the systemic absorption of magnesium or other components of the irrigation solution should be considered.
• Recommendation: Caution should be exercised when Succinic Acid is administered to a nursing woman. Monitor the infant for any signs of gastrointestinal distress or changes in feeding patterns.

• Safety: The safety of Succinic Acid as a calculi dissolution agent in children has not been established.
• Considerations: Children have smaller bladder capacities and are more sensitive to electrolyte shifts. If used, it must be in a highly specialized pediatric urology setting with continuous monitoring.

• Renal Clearance: Elderly patients often have a natural decline in GFR (Glomerular Filtration Rate), making them more susceptible to hypermagnesemia if the irrigation solution contains magnesium.
• Tissue Fragility: The urothelium (lining of the urinary tract) tends to thin with age, increasing the risk of irritation and systemic absorption.
• Polypharmacy: Older adults are more likely to be on medications (like diuretics or ACE inhibitors) that interact with the electrolyte shifts caused by Succinic Acid.

• Mild to Moderate: No specific dose adjustment is usually needed for local irrigation, but serum magnesium and calcium must be monitored every 24-48 hours.
• Severe (GFR < 30 mL/min): Use is generally avoided due to the risk of systemic metabolic acidosis and inability to clear the minerals released from the stones.

No adjustments are required for patients with liver disease. Succinic acid is processed by mitochondria throughout the body, and its clearance is not dependent on hepatic enzyme systems.

> Important: Special populations require individualized medical assessment and more frequent laboratory monitoring during Succinic Acid therapy.

Succinic Acid (butanedioic acid) is a four-carbon dicarboxylic acid with the chemical formula C4H6O4. Its primary clinical mechanism as a Calculi Dissolution Agent involves its role as a proton donor and a ligand for calcium.

• Protonation: In aqueous solution, Succinic Acid dissociates to release hydrogen ions (H+), lowering the pH. This acidity converts insoluble phosphate and carbonate ions in stones into more soluble biphosphate and bicarbonate forms.
• Chelation: The succinate anion (C4H4O4^2-) acts as a bidentate ligand, meaning it can bind to a single calcium ion at two points. This forms a stable, water-soluble chelate complex, effectively pulling calcium out of the stone's solid matrix.

• Onset of Action: The chemical process of dissolution begins immediately upon contact with the stone. However, visible reduction in stone size on imaging typically takes 3 to 7 days of continuous irrigation.
• Duration of Effect: The effect lasts as long as the concentration of the acid is maintained at the stone surface. Once irrigation stops, the urinary pH will return to its baseline within hours.
• Tolerance: There is no known pharmacological tolerance to the chemical dissolution properties of Succinic Acid.

| Parameter | Value |

|---|---|

| Bioavailability | Low (Local Irrigation); High (Oral) |

| Protein Binding | < 5% |

| Half-life | 2 - 10 minutes (Systemic) |

| Tmax | 0.5 - 1 hour (Oral) |

| Metabolism | Mitochondrial (TCA Cycle) |

| Excretion | Renal (< 5% unchanged) |

• Molecular Formula: C4H6O4
• Molecular Weight: 118.09 g/mol
• Solubility: Highly soluble in water (approx. 58 g/L at 20°C).
• Structure: A linear chain of four carbon atoms with a carboxylic acid group (-COOH) at each end.

Succinic Acid is classified as a Calculi Dissolution Agent and an Acidifying Agent. It is related to other organic acids like Citric Acid and Malic Acid, which are also used in various medical and pharmaceutical applications for their buffering and chelating properties.